指南与共识腹部泌尿生殖CT

CT肌少症指标对胃癌术后长期预后的影响

Clinical impact of CT-defined sarcopenia on long-term oncological outcomes in gastric cancer: validation of muscle mass cut-offs established according to EWGSOP recommendations.
指南 / 共识 · Gastric Cancer · 2026-09-03

本回顾性单中心队列研究纳入212例接受胃癌手术且完成5年随访的患者,术前CT评估骨骼肌指数与身高标准化腰大肌厚度。采用基于EWGSOP建议建立的CT参考阈值进行分层,结果显示该阈值可显著区分总生存与无复发生存,联合低骨骼肌指数和低腰大肌厚度提示预后最差。

要点

  • 低骨骼肌指数和低身高标准化腰大肌厚度联合存在时,胃癌术后生存最差
  • 术前CT评估肌少症可辅助胃癌术后风险分层
  • 推荐在胃癌术前CT报告中关注骨骼肌与腰大肌指标

核心结论

  • 基于EWGSOP建议建立的CT参考SMI和PMTH阈值可在胃癌切除术后提供一致的预后分层
  • 联合使用低SMI和低PMTH可识别长期生存特别差的患者

研究设计与样本

  • 回顾性单中心队列研究,纳入2013至2018年接受胃癌手术且具有完整5年随访的212例患者
  • 术前CT评估骨骼肌指数和身高标准化腰大肌厚度
  • 将新近发表的参考阈值与Prado等的SMI定义和Gu等的PMTH定义进行比较
  • 主要终点为总生存,次要终点为无复发生存

诊断标准与关键数值

  • 参考SMI阈值区分总生存和无复发生存的p值均小于0.001
  • 参考PMTH阈值区分总生存和无复发生存的p值均为0.002
  • 联合低SMI和低PMTH的患者总生存和无复发生存最差,p值均小于0.001
  • 单变量分析中,联合低SMI和低PMTH与较差总生存相关,HR为2.57,95%CI为1.54至4.30,p小于0.001
  • 多变量分析中,联合低SMI和低PMTH仍独立与较差总生存相关,HR为1.83,95%CI为1.01至3.30,p等于0.046

临床应用与阅片要点

  • 胃癌术前CT可同时评估SMI和PMTH以识别高危肌少症患者
  • 联合低SMI和低PMTH较单一指标更有助于识别长期生存极差的患者
  • 在报告中可提及肌少症相关测量以辅助多学科治疗决策

局限性

  • 单中心回顾性队列研究

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Sarcopenia is an important prognostic factor in gastrointestinal malignancies, but CT-based definitions vary. This study evaluated recently published computed tomography (CT)-based cut-offs for skeletal muscle index (SMI) and psoas muscle thickness normalized to height (PMTH), derived from a young, presumably healthy reference population according to recommendations of the European Working Group on Sarcopenia in Older People (EWGSOP), in patients undergoing surgery for gastric cancer.

METHODS: This retrospective, single-center cohort study included patients who underwent surgery for gastric cancer between 2013 and 2018. Preoperative CT was used to assess SMI and PMTH. The recently published reference cut-offs were compared with the established definitions of Prado et al. (SMI) and Gu et al. (PMTH). Overall survival (OS) and recurrence-free survival (RFS) were the primary and secondary endpoints, respectively.

RESULTS: Data from 212 patients with complete 5-year follow-up were analyzed. The reference cut-offs significantly discriminated OS and RFS (SMI, both p < 0.001; PMTH, both p = 0.002), whereas the established cut-offs showed weaker or no discrimination. Patients with both low SMI and low PMTH had the worst OS and RFS (both p < 0.001). Combined low SMI and low PMTH was associated with worse OS in univariable analysis (HR 2.57, 95% CI 1.54-4.30, p < 0.001) and remained independently associated in multivariable analysis (HR 1.83, 95% CI 1.01-3.30; p = 0.046).

CONCLUSIONS: The recently published CT-based reference cut-offs for SMI and PMTH provided consistent prognostic stratification after gastric cancer resection, and their combined use identified patients with particularly poor long-term survival.

来源:Gastric Cancer,查看原文。版权归原作者所有。

引用

  1. Hasanovic, Esslinger, Lummer, et al. Clinical impact of CT-defined sarcopenia on long-term oncological outcomes in gastric cancer: validation of muscle mass cut-offs established according to EWGSOP recommendations. Gastric Cancer. 2026. PMID: 42690608. doi:10.1007/s10120-026-01796-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。